To ablate gene expression, 5637 bladder cancer cells, expressing OMD and PRELP at a low level, were transfected with siRNA constructs for OMD or PRELP. After validating the altered expression of OMD and PRELP by RT-PCR, gene expression profiling was performed. Here, PRELP is linked to urinary bladder carcinoma.